Latest news
Argent Biopharma's CannEpil to Target $3bn Veterinary Pain Market, Weeks After Debt-Relief Deal - Business of CannabisBusiness of Cannabis · Thu, 06 Aug 2026 11:23:02 GMTWhat Could Funding Needs Across Early-Stage Businesses Mean For Ananda Developments (LSE:ANA)? - Kalkine MediaKalkine Media · Wed, 05 Aug 2026 10:53:00 GMTMGC Pharmaceuticals (ASX:MXC): Is Funding Risk the Key Signal? - Kalkine MediaKalkine Media · Tue, 04 Aug 2026 03:23:00 GMTHow Celadon Pharmaceuticals (LSE:CEL) And MGC Pharmaceuticals (LSE:MXC) Fit The Latest London Market Rotation - Kalkine MediaKalkine Media · Mon, 27 Jul 2026 07:00:00 GMT